Turns out chronic pain MedsCheck is an intervention few pharmacists want to deliver, and few patients want to be involved with.

Another multi-million dollar pharmacy flop, another therapeutic fail by the Pharmacy Guild of Australia in its endeavours to expand  the pharmacy scope of practice.

The guild always trumpeted the “vital role of pharmacists in chronic pain management”, despite serious clinical concerns.

And so, a $20 million trial was launched in 2018 backed with cash from the Federal Government for pharmacists to assess the medicine regime of adult patients who had experienced chronic pain for at least three months — if the pharmacist felt they were experiencing self-management or dependency issues.¹